MEDI Stock Overview
Develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for MEDI from our risk checks.
Medistim ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 164.00 |
| 52 Week High | NOK 239.00 |
| 52 Week Low | NOK 146.50 |
| Beta | 0.88 |
| 11 Month Change | -1.50% |
| 3 Month Change | -14.14% |
| 1 Year Change | -28.70% |
| 33 Year Change | -57.29% |
| 5 Year Change | -0.61% |
| Change since IPO | 1,492.23% |
Recent News & Updates
Recent updates
Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 19
Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 04One Medistim ASA (OB:MEDI) Analyst Has Been Cutting Their Forecasts
Nov 10What Does Medistim ASA's (OB:MEDI) Share Price Indicate?
Dec 14Should You Be Adding Medistim (OB:MEDI) To Your Watchlist Today?
Sep 06A Look At The Intrinsic Value Of Medistim ASA (OB:MEDI)
Jun 14Medistim (OB:MEDI) Is Increasing Its Dividend To kr3.75
Apr 21Medistim (OB:MEDI) Is Paying Out A Larger Dividend Than Last Year
Mar 31Statutory Profit Doesn't Reflect How Good Medistim's (OB:MEDI) Earnings Are
Mar 05Medistim's (OB:MEDI) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 01Medistim (OB:MEDI) Is Reinvesting To Multiply In Value
Jan 11Medistim (OB:MEDI) Might Become A Compounding Machine
Sep 29Here's Why I Think Medistim (OB:MEDI) Might Deserve Your Attention Today
Sep 07Here's What Medistim's (OB:MEDI) Strong Returns On Capital Mean
May 17Is Medistim ASA's(OB:MEDI) Recent Stock Performance Tethered To Its Strong Fundamentals?
Mar 19Medistim ASA (OB:MEDI) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 02Here's What You Should Know About Medistim ASA's (OB:MEDI) 1.1% Dividend Yield
Feb 19
A Look Into Medistim's (OB:MEDI) Impressive Returns On Capital
Jan 21Have Insiders Been Selling Medistim ASA (OB:MEDI) Shares?
Dec 27Medistim (OB:MEDI) Has Rewarded Shareholders With An Exceptional 375% Total Return On Their Investment
Dec 10Could The Market Be Wrong About Medistim ASA (OB:MEDI) Given Its Attractive Financial Prospects?
Nov 23Shareholder Returns
| MEDI | NO Medical Equipment | NO Market | |
|---|---|---|---|
| 7D | 1.5% | -0.1% | -0.6% |
| 1Y | -28.7% | 13.0% | 5.9% |
Return vs Industry: MEDI underperformed the Norwegian Medical Equipment industry which returned 14.5% over the past year.
Return vs Market: MEDI underperformed the Norwegian Market which returned 6.3% over the past year.
Price Volatility
| MEDI volatility | |
|---|---|
| MEDI Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in NO Market | 10.3% |
| 10% least volatile stocks in NO Market | 2.6% |
Stable Share Price: MEDI has not had significant price volatility in the past 3 months.
Volatility Over Time: MEDI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 151 | Kari Krogstad | www.medistim.com |
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis.
Medistim ASA Fundamentals Summary
| MEDI fundamental statistics | |
|---|---|
| Market cap | NOK 3.00b |
| Earnings (TTM) | NOK 104.34m |
| Revenue (TTM) | NOK 533.17m |
28.8x
P/E Ratio5.6x
P/S RatioIs MEDI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDI income statement (TTM) | |
|---|---|
| Revenue | NOK 533.17m |
| Cost of Revenue | NOK 110.42m |
| Gross Profit | NOK 422.75m |
| Other Expenses | NOK 318.41m |
| Earnings | NOK 104.34m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 24, 2024
| Earnings per share (EPS) | 5.70 |
| Gross Margin | 79.29% |
| Net Profit Margin | 19.57% |
| Debt/Equity Ratio | 0% |
How did MEDI perform over the long term?
See historical performance and comparison